With extensive experience across multiple investment stages, the fund manager has built a diverse portfolio focusing on technology and healthcare sectors. Active in North America and Europe, they have successfully executed over 30 deals, showcasing a strategic, operator-first approach. Notable exits include leading firms in the biotech space, demonstrating a keen ability to identify and scale high-potential opportunities. Their data-driven investment style emphasizes thorough market analysis, which has consistently yielded strong returns.